By building a cancer gene panel encompassing 150 different cancer related genes, the NCC-GP150, they calculated bTMB levels of a cohort of 50 NSCLC patients receiving anti-PD-1/PD-L1 immunotherapy [83]. Here, CD274 is linked to non-small cell lung carcinoma.